Engineered <i>Lactococcus lactis</i> Secreting IL-23 Receptor-Targeted REX Protein Blockers for Modulation of IL-23/Th17-Mediated Inflammation
<i>Lactococcus lactis</i>, a probiotic bacterium of food origin, has recently been demonstrated as a suitable strain for the production and in vivo delivery of therapeutically important proteins into the gut. We aimed to engineer recombinant <i>L. lactis</i> cells producing/s...
Main Authors: | Tina Vida Plavec, Milan Kuchař, Anja Benko, Veronika Lišková, Jiří Černý, Aleš Berlec, Petr Malý |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/7/5/152 |
Similar Items
-
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
by: Claudia Schinocca, et al.
Published: (2021-02-01) -
The regulatory mechanism and potential application of IL-23 in autoimmune diseases
by: De-Kai Xiong, et al.
Published: (2022-09-01) -
Dual Functionalized Lactococcus lactis Shows Tumor Antigen Targeting and Cytokine Binding in Vitro
by: Abida Zahirović, et al.
Published: (2022-01-01) -
The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
by: Taoming Liu, et al.
Published: (2020-11-01) -
No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors
by: Hua Zhang, et al.
Published: (2022-02-01)